CL

Calidi Biotherapeutics IncNYSE-MKT CLDI Stock Report

Last reporting period 31 Dec, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.009

Micro

Exchange

XASE - Nyse MKT LLC

View Full Company Analysis

Calidi Current ratio

Last period Current ratio


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

View Full Company Analysis